Director/PDMR Shareholding
Genedrive plc announced that on August 28, 2026, Chief Executive Officer Dr. Gino Miele purchased 700,000 ordinary shares at 1.38p each, and Chief Financial Officer Russ Shaw acquired 700,000 ordinary shares at 1.40p each. Following these transactions, Dr. Miele now holds 7,902,187 ordinary shares, representing 0.49% of the issued share capital, and Mr. Shaw holds 8,400,000 ordinary shares, representing 0.52% of the issued share capital. These purchases indicate confidence from key management in the company's prospects.
Select text to share a quote on X · sign in to keep highlights & notes in your GDR notes
genedrive plc (AIM: GDR), the point of care pharmacogenetic testing company announces that on 28 August 2026, Dr Gino Miele, Chief Executive Officer, acquired 700,000 Ordinary Shares in the Company at a price of 1.38p per share and Russ Shaw, Chief Financial Officer, acquired 700,000 Ordinary Shares in the Company at a price of 1.40p per share.
Following these purchases, Dr Gino Miele, is interested in 7,902,187 Ordinary Shares, 0.49% of the issued share capital of the Company and Russ Shaw is interested in 8,400,000 Ordinary Shares, 0.52% of the issued share capital of the Company.
| 1. | Details of the person discharging managerial responsibilities / person closely associated | |
| a. | Name | 1. Dr Gino Miele 2. Russ Shaw |
| 2. | Reason for the notification | |
| a. | Position/status | 1. Chief Executive Officer 2. Chief Financial Officer |
| b. | Initial notification /Amendment | Initial notification |
| a. | Name | genedrive plc |
| b. | LEI | 213800ZYODIRZ87Y4K14 |
| a. | Description of the Financial instrument, type of instrument Identification code | Ordinary Shares of 0.015p each GB00B1VKB244 |
| b. | Nature of the transaction | Purchase of ordinary shares |
| c. | Price(s) and volume(s) | Price(s) Volume(s) 1. 1.38p 2. 1.40p 700,000 700,000 |
| d. | Aggregated information · Aggregated volume · Price | 1. £9,660.00 2. £9,800.00 |
| f. | Place of the transaction | London Stock Exchange, AIM Market (XLON) |
| genedrive plc | +44 (0)161 989 0245 | |
| Gino Miele: CEO / Russ Shaw: CFO | https://investors.genedrive.com/s/e0025c | |
| Peel Hunt LLP (Nominated Adviser and Broker) | +44 (0)20 7418 8900 | |
| James Steel | ||
| 5654 & Company (Media & Investor Relations) | genedrive@5654.co.uk | |
| Matthew Neal | +44 (0)7917 800 011 | |
| Melissa Gardiner | +44 (0)7757 697357 | |
Subscribe to our news alert service: https://investors.genedrive.com/s/efea03
About genedrive plc (http://www.genedrive.com).
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.